Impact of a multidisciplinary intervention for diabetes in Eritrea

Clinical Chemistry

Volumn 53, Issue 11, 2007, Pages 1954-1959

  Windus, David W ^a   Ladenson, Jack H ^a,b   Merrins, Cindy K ^b   Seyoum, Melles ^c   Windus, Debra ^b   Morin, Susan ^b   Tewelde, Beyene ^d   Parvin, Curtis A ^a   Scott, Mitchell G ^a   Goldfeder, Jason ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Pathologists Overseas Inc   (United States)

^c National Health Laboratory   (Eritrea)

^d Halibet Hospital   (Eritrea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; DEMOGRAPHY; DEVELOPING COUNTRY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE DURATION; EDUCATION PROGRAM; ERITREA; FEMALE; HUMAN; HYPERTENSION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MONITORING; PREVALENCE; PROTEINURIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIABETES COMPLICATIONS; DIABETES MELLITUS; EDUCATION, CONTINUING; ERITREA; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT EDUCATION AS TOPIC; PREVALENCE; PROGRAM DEVELOPMENT;

EID: 35648988909     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.095067     Document Type: Article

References (16)

1. International Diabetes Foundation. Diabetes Atlas, 3rd ed. http://www.eatlas.idf.org/webdata/docs/Figure%201.4_lg.jpg (accessed July 8, 2007).
2. Aspray TJ, Unwin N. Diabetes in Sub-Saharan Africa. Adv Exp Med Biol 2001;498:21-6.
3. Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF. Diabetes in Africans: part 1: epidemiology and clinical specificities. Diabetes Metab 2001;27:628-34.
4. Motala AA, Omar MA, Pirie FJ. Diabetes in Africa: epidemiology of type 1 and type 2 diabetes in Africa. J Cardiovasc Risk 2003;10:77-83.
5. Osei K, Schuster DP, Amoah AG, Owusu SK. Diabetes in Africa. Pathogenesis of type 1 and type 2 diabetes mellitus in Sub-Saharan Africa: implications for transitional populations. J Cardiovasc Risk 2003;10:85-96.
6. WHO. STEPS: A framework for surveillance. http://www.who.int/chp/steps/ manual/en/ (accessed June 1, 2006).
7. Ladenson JH, Scott MG, Klarkowski D, Seyoum M. Use of a major medical center clinical laboratory as a reference laboratory for a developing country: ordering patterns help set laboratory priorities. Clin Chem 2003;49:162-6.
8. Scott MG, Morin S, Hock KG, Seyoum M, Ladenson JH. Establishing a simple and sustainable quality assurance program and clinical chemistry services in Eritrea. Clin Chem 2007;53:1945-53.
9. Kengne AP, Amoah AG, Mbanya JC. Cardiovascular complications of diabetes in Sub-Saharan Africa. Circulation 2005;112:3592-601.
10. Swai AB, McLarty DG, Alberti KG. IDDM in Sub-Saharan Africa. Diabet Med 1993;10:188.
11. Mauvais-Jarvis F, Sobngwi E, Porcher R, Riveline JP, Kevorkian JP, Vaisse C, et al. Ketosis-prone type 2 diabetes in patients of Sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes 2004;53:645-53.
12. Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF. Diabetes in Africans, part 2: ketosis-prone atypical diabetes mellitus. Diabetes Metab 2002;28:5-12.
13. Coleman R, Gill G, Wilkinson D. Noncommunicable disease management in resource-poor settings: a primary care model from rural South Africa. Bull World Health Organ 1998;76:633-40.
14. Mbanya JC, Mbanya D. Diabetes cost in Sub-Saharan Africa. J Cardiovasc Risk 2003;10:191-3.
15. Yudkin JS. Insulin for the world's poorest countries. Lancet 2000;355:919-21.
16. Lester FT. Insulin therapy: problems in an African country. Diabet Med 1985;2:405-7.